Page 310 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 310

296     SECTION IV  Drugs with Important Actions on Smooth Muscle


                 cavity, and the endocardial tissue of the heart.  These changes   was sometimes used as a substitute for LSD by members of the
                 occurred insidiously over months and presented as hydronephro-  so-called drug culture.
                 sis (from obstruction of the ureters) or a cardiac murmur (from   Contraindications to the use of ergot derivatives consist of the
                 distortion of the valves of the heart). In some cases, valve damage   obstructive vascular diseases, especially symptomatic coronary
                 required surgical replacement. As a result, this drug was with-  artery disease, and collagen diseases.
                 drawn from the US market. Similar fibrotic change has resulted   There is no evidence that ordinary use of ergotamine for
                 from the chronic use of non-ergot 5-HT agonists promoted in the   migraine is hazardous in pregnancy. However, most clinicians
                 past for weight loss (fenfluramine, dexfenfluramine).  counsel restraint in the use of the ergot derivatives by preg-
                   Other toxic effects of the ergot alkaloids include drowsi-  nant patients. Use to deliberately cause abortion is contrain-
                 ness and, in the case of methysergide, occasional instances of   dicated because the high doses required often cause dangerous
                 central  stimulation and hallucinations. In fact, methysergide   vasoconstriction.





                  SUMMARY Drugs with Actions on Histamine and Serotonin Receptors; Ergot
                  Alkaloids

                                    Mechanism                            Clinical       Pharmacokinetics, Toxicities,
                  Subclass, Drug    of Action      Effects               Applications   Interactions

                  H 1  ANTIHISTAMINES
                  First generation:
                    •  Diphenhydramine  Competitive   Reduces or prevents histamine   IgE immediate   Oral and parenteral • duration 4–6 h • Toxicity:
                                    antagonism/inverse   effects on smooth muscle,   allergies; especially   Sedation when used in hay fever, muscarinic
                                    agonism at H 1    immune cells • also blocks   hay fever, urticaria    blockade symptoms, orthostatic hypotension
                                    receptors      muscarinic and α adrenoceptors   • often used as a   • Interactions: Additive sedation with other
                                                   • highly sedative     sedative, antiemetic,   sedatives, including alcohol • some inhibition of
                                                                         and anti-motion   CYP2D6, may prolong action of some β blockers
                                                                         sickness drug
                  Second generation:
                    •  Cetirizine   Competitive    Reduces or prevents histamine   IgE immediate   Oral • duration 12–24 h • Toxicity: Sedation and
                                    antagonism/inverse   effects on smooth muscle,   allergies; especially   arrhythmias in overdose • Interactions: Minimal
                                    agonism at H 1    immune cells       hay fever, urticaria
                                    receptors
                    •   Other first-generation H 1  blockers: Chlorpheniramine is a less sedating H 1  blocker with fewer autonomic effects. Doxylamine, a strongly sedating H 1  blocker, is available
                    over-the-counter in many sleep-aid formulations and in Diclegis (in combination with pyridoxine) for use in nausea and vomiting of pregnancy
                    •  Other second-generation H 1  blockers: Loratadine, desloratadine, and fexofenadine are very similar to cetirizine

                  H 2  ANTIHISTAMINES
                    •  Cimetidine, others (see Chapter 62)
                  SEROTONIN AGONISTS
                  5-HT 1B/1D :
                    •  Sumatriptan  Partial agonist at   Effects not fully understood   Migraine and cluster   Oral, nasal, parenteral • duration 2 h • Toxicity:
                                    5-HT 1B/1D  receptors  • may reduce release of   headache  Paresthesias, dizziness, coronary
                                                   calcitonin gene-related peptide      vasoconstriction • Interactions: Additive with
                                                   and perivascular edema in            other vasoconstrictors
                                                   cerebral circulation
                    •   Other triptans (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, zolmitriptan): Similar to sumatriptan except for pharmacokinetics (2–6 h duration of action);
                    much more expensive than generic sumatriptan

                  5-HT 2C :
                    •  Lorcaserin   Agonist at 5-HT 2C    Appears to reduce appetite  Obesity  Oral • duration 11 h • Toxicity: Dizziness,
                                    receptors                                           headache, constipation

                  5-HT 4 :
                    •  Tegaserod (see Chapter 62)

                                                                                                                (continued)
   305   306   307   308   309   310   311   312   313   314   315